25 May 2013
Keywords: uk, nice, latest, decision, gsk, tyverb, pfizer
Article | 16 March 2009
Despite recent indications that the UK's National Institute for Health and Clinical Excellence (NICE) might be more flexible on
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 2009
24 May 2013
© 2013 thepharmaletter.com